欢迎访问《临床药物治疗杂志》官方网站,今天是

图/表 详细信息

四环素类药物的临床综合评价
田晶辰, 陈瑞玲
临床药物治疗杂志, 2025, 23(6): 60-66.   DOI: 10.3969/j.issn.1672-3384.2025.06.010

药品编号药学特性有效性安全性经济性其他属性综合得分
MNJ-100-A23.024.018.910.06.882.7
MNJ-50-B23.024.018.97.56.079.4
MNJ-100-B23.024.018.98.86.080.7
MNJ-50-C23.024.018.92.36.574.7
MNP-50-D23.024.018.97.66.079.5
MNP-50-E23.024.018.92.66.074.5
DXP-100-F10023.524.018.910.07.583.9
DXP-100-F2423.524.018.90.57.574.4
DXP-100-G23.524.018.90.17.073.5
DXJ-100-H23.524.018.93.45.074.8
DXZ-100-I22.024.018.93.03.571.4
AMZ-100-J22.020.014.99.84.671.3
AMP-150-K24.020.014.910.04.072.9
YLZ-50-L22.022.017.910.03.575.4
TJZ-50-M22.527.017.910.05.082.4
TJZ-50-N21.027.017.98.56.580.9
TJZ-50-O21.027.017.91.55.572.9
TJZ-50-P22.527.017.91.25.373.9
TJZ-50-J22.527.017.92.85.175.3
TJZ-50-Q22.527.017.92.24.574.1
表8 20种不同生产厂家四环素类药物的综合得分(分)
本文的其它图/表